FOXO4
Preclinical — Animal / cell-model data onlyWhat it is
A senolytic peptide (FOXO4-DRI) studied for clearing senescent cells in animal models. Early-stage.
FOXO4-DRI is a senolytic peptide studied for clearing senescent ('aged') cells in animal models. It is very early-stage with no human safety data.
Research context
Studied in relation to:
- Senolytic/longevity research (animal)
Points in its favour in the literature:
- Interesting senolytic mechanism
Caveats and unknowns:
- Animal-stage only
- No human safety data
- Unlicensed
Handling & reference data
Route in published researchAnimal research only; no established human route.
Published clinical / research context (not instructions)No human dose established — animal research only.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)For laboratory handling, e.g. 10 mg + 2 mL → 5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 10mg | F410 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.